Market Place
Sourcing Support
All News #Library
Biotech
Scancell Wins FDA Fast Track for iSCIB1+ in Advanced Melanoma
28 Apr 2026 //
GLOBENEWSWIRE
Interim Results for the six months ended 31 October 2025
29 Jan 2026 //
GLOBENEWSWIRE
Scancell Receives FDA IND Clearance for Phase 3 Melanoma Trial
26 Jan 2026 //
GLOBENEWSWIRE
Pharmajet Chosen For Advanced Melanoma DNA Immunotherapy
09 Jan 2026 //
BUSINESSWIRE
Scancell`s iSCIB1+ Improves PFS in Advanced Melanoma
09 Dec 2025 //
GLOBENEWSWIRE
Research Update
07 Nov 2025 //
GLOBENEWSWIRE
Scancell`s Business Update & Financial Results for 2025 Released
11 Sep 2025 //
GLOBENEWSWIRE
Scancell Picks Winner from Phase 2 Cancer Vaccine Face-Off
23 Jul 2025 //
FIERCE BIOTECH
Genmab buys 2nd antibody from Scancell in deal worth up to $630M
04 Dec 2024 //
FIERCE BIOTECH
PharmaJet Partner, Scancell, Announces Positive Data from Phase 2 Trial
28 Sep 2023 //
BUSINESSWIRE
Scancell enjoys stock bounce on back of cancer vaccine data
19 Sep 2023 //
FIERCE BIOTECH
Scancell shares encouraging results from phase 1/2 cancer trial
21 Feb 2023 //
PHARMAFILE
Giving first glimpse of data, Scancell looks for Covid-19 vaccine partner
13 Feb 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.